CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income	Treasury Stock [Member]
Beginning Balance at Dec. 31, 2019	$ 2,833,620	$ 2,694	$ 2,875,680	$ 1,294,902	$ 5,478	$ (1,345,134)
Beginning Balance (in shares) at Dec. 31, 2019		269,372
Net Income (loss)	(803,692)			(803,692)
Foreign currency translation adjustment	(66)				(66)
Release of cumulative translation adjustment	0
Issuance of restricted stock		$ 3	(3)
Issuance of restricted stock (in shares)		333
Vesting of restricted stock units		$ 13	(13)
Vesting of restricted stock units (in shares)		1,324
Stock-based compensation	26,572		26,572
Payment of cash dividends	(18,862)			(18,862)
Dividend equivalents	(334)			(334)
Purchase of treasury stock	(21,179)					21,179
Ending Balance at Dec. 31, 2020	2,016,059	$ 2,710	2,902,236	472,014	5,412	(1,366,313)
Ending Balance (in shares) at Dec. 31, 2020		271,029
Net Income (loss)	(654,545)			(654,545)
Foreign currency translation adjustment	503				503
Release of cumulative translation adjustment	0
Restricted stock issued for acquisition	248,025	$ 263	247,762
Restricted stock issued for acquisition (in shares)		26,274
Issuance of restricted stock		$ 6	(6)
Issuance of restricted stock (in shares)		621
Vesting of restricted stock units		$ 14	(14)
Vesting of restricted stock units (in shares)		1,345
Stock-based compensation	21,558		21,558
Payment of cash dividends	(15,605)			(15,605)
Dividend equivalents	(180)			(180)
Purchase of treasury stock	(6,328)					6,328
Ending Balance at Dec. 31, 2021	$ 1,609,487	$ 2,993	3,171,536	(198,316)	5,915	(1,372,641)
Ending Balance (in shares) at Dec. 31, 2021	299,268,967	299,269
Net Income (loss)	$ 154,658			154,658
Foreign currency translation adjustment	1,793				1,793
Release of cumulative translation adjustment	(7,708)				$ (7,708)
Issuance of restricted stock		$ 10	(10)
Issuance of restricted stock (in shares)		980
Vesting of restricted stock units		$ 14	(14)
Vesting of restricted stock units (in shares)		1,437
Exercise of stock options	$ 10,368	$ 6	10,362
Exercise of stock options (in shares)	640,000	640
Stock-based compensation	$ 21,099		21,099
Payment of cash dividends	(43,096)			(43,096)
Dividend equivalents	(640)			(640)
Purchase of treasury stock	(80,438)					80,438
Ending Balance at Dec. 31, 2022	$ 1,665,523	$ 3,023	$ 3,202,973	$ (87,394)		$ (1,453,079)
Ending Balance (in shares) at Dec. 31, 2022	302,325,853	302,326